FIELD: medicine.
SUBSTANCE: invention represents a polymer complex of chitosan and colloidal gold, contains 8 to 21 % (wt) of gold with particle size approximately 1 nm, possesses antituberculosis activity with respect to drug-resistant tuberculosis mycobacteria.
EFFECT: higher effectiveness of antituberculosis action with respect to the strains with multiple drug-resistant stability.
2 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF TREATING INFILTRATIVE PULMONARY TUBERCULOSIS INDUCED BY MULTIPLE-DRUG-RESISTANT AND HIGHLY TOXIC STRAINS OF MYCOBACTERIA TUBERCULOSIS | 2009 |
|
RU2423129C1 |
| MEANS, POSSESSING ANTI-TUBERCULOSIS ACTION | 2014 |
|
RU2549477C1 |
| COFORMULATED ANTITUBERCULOUS DRUG | 2009 |
|
RU2430724C2 |
| ANTI-TUBERCULOSIS AGENT | 2017 |
|
RU2657423C1 |
| 5-METHYL-7-(3-NITRO-[1,2,4]TRIAZOL-1-YL)-[1,2,4]TRIAZOLO[1,5-A]PYRIMIDINE, HAVING ANTI-TUBERCULOSIS ACTIVITY AGAINST THE AGENT WITH MULTIPLE DRUG RESISTANCE, AND A METHOD FOR PRODUCTION THEREOF | 2018 |
|
RU2705591C1 |
| ANTI-TUBERCULOSIS MEDICATION BASED ON 4-THIOUREIDOIMINOMETHYLPYRIDINIUM PERCHLORATE, METHOD OF ITS OBTAINING AND METHOD OF TREATMENT | 2010 |
|
RU2423977C1 |
| METHOD FOR PRODUCING POLYMERIC COMPLEX | 2010 |
|
RU2435611C1 |
| METHOD FOR PRODUCING POLYMER CONJUGATE OF ISONICOTINIC ACID HYDRAZONE | 2010 |
|
RU2454226C1 |
| STRAIN MYCOBACTERIUM TUBERCULOSIS 326/18/47 B-9673 FOR EVALUATION OF THE EFFECTIVENESS OF ANTI-TB DRUGS AND DISINFECTANTS | 2022 |
|
RU2785409C1 |
| METHOD OF TREATING TUBERCULOSIS WITH MULTIPLE DRUG RESISTANCE | 2013 |
|
RU2554753C2 |
